6,678 trials
Migraine
Primary: Migraine Functional Impact Questionnaire (MFIQ) - "Overall Impact on Usual Activities" Scores at Baseline and at End of Treatment (Treatment Month 3). — 43.64; 21.82…
Urinary Incontinence · Urgency Urinary
Primary: Inflammatory Markers in Urine Will be Measured Using Immunoenzyme Assays to Measure the Interaction of Anticholinergic Treatment and the Inflammatory Milieu. — 2.192…
Psoriasis
Primary: Efficacy as Measured by the Mean Percentage Change in the Product of Static Physician Global Assessment (sPGA) and Body Surface Area (BSA). — 53.06; 65.6 percentage of…
Colonic Polyp
Primary: Immediate Post-polypectomy Pain — 46.5; 13.6 units on a scale
COVID-19 · Cytokine Storm
Primary: Number of Outpatient Subject Hospitalizations — 0; 0 Participants
Synkinesis
Primary: Change in Sunnybrook Facial Grading System (SFGS) Between Baseline and 4 Month Scoring — 0.29; 5.86 score on a scale
Liver Transplantation
Primary: Renal Recovery/ Function — 28; 26 Participants
Loiasis
Primary: Cross-reactive Antigenemia — 12 Participants
HIV
Primary: Number of Participants With HIV Viral Load Suppression in Plasma — 2; 1; 84; 8 Participants
Anemia
Primary: Non-transferrin Bound Iron — 56230; 61250 ppb x hours
Orthostatic Hypotension · Idiopathic Parkinson Disease
Primary: Orthostatic Hypotension Questionnaire (OHQ) Score — 4.6 score on a scale
Venous Thromboembolism · Ovarian Cancer
Primary: Number of Participants Experiencing a Venous Thromboembolism — 4 Participants
Diabetes Complications
Primary: Percentage of Participants Reporting Adverse Events (AE) — 0 percentage of participants
Tibial Tubercle Osteotomy
Primary: Perioperative Blood Loss — 67.8; 56.15 mL
Breast Surgery
Primary: Mean/Median Numeric Rating Scale Pain Score Within the Recovery Room — 4; 0 score on a scale — p=0.001